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Abstract
Background: Alterations of cardiac autonomic control (CAC) are associated with poor outcomes in patients with
infectious and non-infectious diseases. No evaluation of CAC in patients with community-acquired pneumonia
(CAP) has been performed so far. The aim of the study was to assess CAC in patients with CAP and evaluate the
impact of its alterations on disease severity and clinical outcomes in a multicenter, prospective, observational study.
Methods: Consecutive patients hospitalized for CAP were enrolled between 2011 and 2013 two university hospitals
in Italy. CAC was assessed by linear spectral and non-linear symbolic analysis of heart rate variability. The presence
of severe CAP was evaluated on hospital admission. The primary study outcome was time to clinical stability (TCS)
during hospitalization.
Results: Among the 75 patients enrolled (median age: 75 years; 57 % males), a significantly lower total variability
and reduction of sympathetic rhythmical component with predominant respiratory modulation was detected in
comparison to controls. Among CAP patients affected by a severe CAP on admission, CAC showed a lower
sympathetic modulation and predominant parasympathetic oscillatory rhythm. At the multivariate analysis, variables
independently correlated with a TCS >7 days were total power, as marker of total variability, [OR (95 % CI): 0.997
(0.994–1.000), p = 0.0454] and sympathetic modulation [OR (95 % CI): 0.964 (0.932–0.998), p = 0.0367].
Conclusions: Loss of sympathetic rhythmical oscillation is associated with a more severe disease and worse early
clinical outcome in hospitalized patients with CAP.
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Background
Community-acquired pneumonia (CAP) represents the
first cause of death for infectious diseases in western
countries, with a mortality rate that has remained stable
since the introduction of antibiotics in the 1940s [1].
During the past years, several efforts have been focused
on exploring new approaches and testing strategies to
reduce mortality by reducing complications related to
pneumonia. Recent evidence has particularly shown that
cardiovascular events (CVE) might occur in up to 30 % of
hospitalized patients with CAP leading to an increase
short and long-term mortality [2–5]. A better understand-
ing of the physiopathological pathways sustaining the
association between CAP and CVE is still needed in order
to target interventions to improve patients’ outcomes.
It has been hypothesized that an alteration of cardiac
autonomic control (CAC), as assessed by heart rate vari-
ability (HRV), may play a key role among the complex
interaction of events that may lead to the occurrence of
CVE during CAP [4–8]. This alteration is characterized by
a reduction of total variability and an altered sympatho-
vagal balance. Previous literature reported an alteration of
CAC in several cardiovascular diseases, including congest-
ive heart failure and myocardial infarction, and it has
shown that it is strongly associated with poor outcomes
[9–11]. The impact of infections on CAC has been evalu-
ated so far only in patients with severe sepsis who show a
lower total HRV and impaired sympathetic modulation
[12]. No previous experiences have been designed to study
CAC in a specific population of patients with CAP.
The aim of this study was to evaluate CAC in hospital-
ized patients with CAP and particularly the impact of
possible autonomic alterations on both disease severity
on admission and early clinical outcomes.
Methods
Study design and population
This was a pilot, multicenter, prospective, observational
study on consecutive patients who were hospitalized be-
cause of an episode of CAP at the Respiratory Units of the
Policlinico Hospital in Milan and the San Gerardo Hospital
in Monza, Italy, from September 2011 to January 2013. The
study was approved by the San Gerardo Hospital institu-
tional review boards (IRB) in Monza (FAILCAP;10.2.2011)
and the IRCCS Fondazione Cà Granda Policlinico IRB
(nr.1686;FAILCAP) in Milan. An informed consent was
signed by all participants. Patients with a diagnosis of
CAP who showed a stable sinus rhythm on the electro-
cardiogram (ECG) performed on hospital admission
were included in the study. Patients with a diagnosis of
healthcare-associated pneumonia were included in the
study [13]. Patients with at least one among the following
were excluded from the study: 1) pneumonia that devel-
oped in a patient who was discharged from the hospital
within the prior 14 days of hospital admission; 2) absence
of sinus rhythm on ECG at hospital admission; 3) patients
with pacemaker rhythm on ECG at hospital admission; 5)
patients undergoing mechanical ventilation, in whom the
application of a positive pressure might alter the eva-
luation of CAC; 6) patients on chronic treatment with
inhaled long acting either muscarinic agents (LAMA) or
beta agonists. Subjects without chronic respiratory, car-
diovascular, and metabolic diseases matched for age and
sex with the CAP group were recruited in a general pra-
ctitioner clinic during the same period and enrolled as
Control group. These subjects were on neither respiratory
nor cardiovascular medications.
Data collection
The clinical management of patients, laboratory evalua-
tions and antimicrobial therapy were performed according
to the current standard of care for patients with CAP [14].
Patients were seen daily during their hospital stay by
one or more of the investigators who recorded clin-
ical data, see Additional file 1. Microbiological exami-
nations were performed on sputum, urine, and blood
during the first 24 h after admission and according to
standard of practice, see Additional file 1 [15]. Empiric
antibiotic therapy was administered in compliance with
the European Respiratory Society guidelines [14]. Severe
CAP was defined according to the 2007 American Thor-
acic Society/Infectious Diseases Society of America guide-
lines [16].
Assessment of cardiac autonomic control
In order to evaluate the cardiac autonomic control, pa-
tients underwent the recording of ECG and respiratory
movements using a thoracic piezoelectric belt before
empiric antibiotic treatment and within the 6 h after
admission to the hospital. Control group underwent the
recording of ECG and respiratory movements using the
same device (see Additional file 1).
Cardiac autonomic control was evaluated using a clas-
sical linear spectral analysis and a more recent non-
linear symbolic analysis [6]. Spectral analysis assesses the
rhythmic oscillatory components that characterize the
heart period time series and it identifies three main
oscillations embedded in heart period time series: very
low frequency component (VLF), low frequency compo-
nent (LF) marker of sympathetic modulation and high
frequency component (HF), synchronous with respir-
ation and marker of vagal modulation. On the other
hand, symbolic analysis is a non-linear method able to
evaluate autonomic cardiac modulation and to detect
non-reciprocal changes of sympathetic and parasympa-
thetic modulations on heart period time series [17–20].
Mathematical and technical details are reported in the
Additional file 1.
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Study outcomes
In order to evaluate the impact of alterations of CAC on
pneumonia-related outcomes, time to clinical stability
(CS) has been identified as the primary study outcome,
see Additional file 1 [21, 22]. Secondary study outcomes
were cardiovascular events (CVE), length of hospital stay
(LOS) and 30-day mortality. Types and definitions of
CVE are reported in the Additional file 1. LOS was
calculated as number of days from the date of admission
to the date of discharge. Thirty-day mortality was con-
sidered if death by any cause occurred during the first
30 days after the diagnosis of pneumonia. Mortality for
patients who have been discharged before 30 days after
the diagnosis of pneumonia was evaluated by a phone
call at 30 days.
Statistical analysis
Descriptive statistics were reported at baseline, with con-
tinuous data expressed as means ± standard deviation for
normally distributed data or as median (interquartile
range -IQR) for skewed data, and categorical data expressed
as counts. Patient characteristics were compared between
groups: patients with severe CAP versus patients with non-
severe CAP; patients with TCS ≤7 days versus patients with
TCS >7 days. Differences of continuous data between
groups were evaluated by unpaired t-test or Mann–
Whitney U test. Univariate and multivariate logistic
regression analyses were performed to assess association
between the time to clinical stability (dichotomized, ≤7 vs.
>7 days) and the following variables: heart rate (HR), total
power (TP), VLF, LFa, HFa, LFnu, HFnu, LF/HF, central
frequency of respiration (RESPHF), 0V%, 1V%, 2LV%,
2UV% and Pneumonia Severity Index (PSI), see the
Additional file 1 [22, 23]. Sample size calculation is also
reported in the Additional file 1. A p value <0.05, two
sided, was considered statistically significant. All the
statistical analyses were performed with SAS statistical
software (release 9.4; SAS Institute Inc, Cary, NC).
Results
Study population
Among the 105 patients who were screened during the
study period, 30 were excluded: 10 refused to give the
informed consent, 6 had cardiac arrhythmias on hos-
pital admission, 6 underwent mechanical ventilation on
admission, 4 had a pacemaker and 4 were on LAMA.
The final study population was composed by 75 pa-
tients (median age: 75 years; 57 % males). Baseline
demographics, comorbidities, disease severity, clinical
and laboratory findings on admission, microbiology,
and antibiotic therapy of the study population are sum-
marized in Table 1. A total of 26 healthy controls
(median age: 68 years; 58 % males) were enrolled during
the same period.
Cardiac autonomic control in CAP patients
In comparison to controls, CAP patients were character-
ized by significantly higher HR and by a significant
reduction of total variability, as shown by lower level of
total power and VLF component. As to sympatho-vagal
balance, CAP patients showed lower level of LFnu,
marker of sympathetic modulation, and an increase of
2UV%, marker of parasympathetic modulation, in com-
parison to controls, see Table 2.
Cardiac autonomic control and CAP severity on admission
A total of 19 patients (25 %) had severe CAP on hospital
admission. Complete data on cardiac autonomic modula-
tion of the study population according to different severity
of the disease on hospital admission are reported in
Additional file 1: Table S1. In comparison to patients with-
out severe CAP, those with severe CAP on admission
showed a significant higher median HR [78 (68–88) vs. 83
(80–98) bpm, p = 0.021], significant lower median VLF
component [84 (9–177) vs. 13 (0.1–41) ms2, p = 0.004],
significant median lower 0V% [28 (16–39) vs. 16 (6–35),
p = 0.047], marker of sympathetic modulation, and sig-
nificant higher median 2UV% [20 (12–35) vs. 38 (19–47),
p = 0.011], marker of parasympathetic modulation, sug-
gesting a global shift of the sympatho-vagal balance to-
wards vagal predominance (see Fig. 1). The univariate
logistic regression analysis for the presence of severe CAP
on hospital admission is reported in Additional file 1:
Table S2. At the multivariate analysis, variables independ-
ently correlated to severe CAP on admission were HR
[OR (95 % CI): 1.078 (1.025–1.134), p = 0.004] and 2UV%
[OR (95 % CI): 1.042 (1.001–1.084), p = 0.044], c-statistic
for the multivariate model: 0.804.
As additional analysis, we compared autonomic control
in CAP patients with vs. without severe sepsis. As shown
in Table 1, we had in our sample 14 patients (19 %) with
severe sepsis and 61 (81 %) without severe sepsis. The
comparison of autonomic parameters between these two
groups showed that heart rate was higher in the severe
sepsis group compared to non severe sepsis group (88 vs
79 bpm, p = 0.04) and only 2UV%, symbolic marker of
parasympathetic modulation, was higher in the severe
sepsis group compared to non severe sepsis group (36 vs
25 %, p = 0.01).
Cardiac autonomic control and CAP outcomes
A total of 48 patients (64 %) reached clinical stability before
7 days of hospital admission. In comparison to patients
who reached CS within 7 days, those who reached CS after
7 days had significant lower total power (p = 0.001) and
lower VLF component (p = 0.003). A complete report
of both spectral and symbolic analysis is depicted in
Table 3. The univariate logistic regression analysis for
TCS >7 days is reported in Additional file 1: Table S3.
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At the multivariate analysis, variables independently cor-
related with a TCS >7 days were total power [OR (95 %
CI): 0.997 (0.994–1.000), p = 0.045], 0V% [OR (95 % CI):
0.964 (0.932–0.998), p = 0.037] and Resp HF [OR (95 %
CI): 1.092 (1.022–1.167), p = 0.009], c-statistic for the
multivariate model: 0.813.
Among the study population one patient experienced
a myocardial infarction, two patients an acute cardio-
genic pulmonary edema and two patients a new cardiac
arrhythmia during hospitalization. All these patients ex-
periencing CVE reached CS after 7 days of hospitalization.
The median (IQR) LOS in the entire study population was
9 (7–14) days. A total of 5 patients died within 30 days
after the diagnosis of pneumonia.
Discussion
This pilot study demonstrates that cardiac autonomic
profile of CAP patients is characterized by a lower total
variability and loss of sympathetic rhythmical component
with predominant respiratory modulation in comparison to
controls. Among patients with severe CAP, cardiac auto-
nomic control shows a lower sympathetic modulation and
predominant parasympathetic oscillatory rhythm. Finally,
Table 1 Baseline demographics, comorbidities, disease severity,
clinical and laboratory findings on admission, microbiology, and
antibiotic therapy of the study population
Study population n = 75
Demographics, n. (%)
Male 43 (57)
Age, median (IQR) years 75 (59–84)
Body mass index, median (IQR) 24 (20–27)
Healthcare-associated pneumonia 5 (7)
Comorbidities, n. (%)
Active neoplastic disease 12 (16)
Chronic obstructive pulmonary disease 18 (24)
Diabetes mellitus 11 (15)
Cerebrovascular accident 9 (12)
Liver disease 5 (7)
Neurological diseases 11 (15)
Renal disease 8 (11)
Chronic renal failure 6 (8)
Family history of coronary artery disease 16 (21)
Essential arterial hypertension 36 (48)
Congestive heart failure 7 (9)
Active coronary artery disease 12 (16)
Prior acute myocardial infarction 10 (13)
Atrial fibrillation 2 (3)
Hyperlipidemia 14 (19)
Medications before admission, n. (%)
Aspirin 17 (23)
Beta-blockers 13 (17)
Angiotensin-converting-enzyme inhibitors 14 (19)
Antiplatelets 8 (11)
Statins 12 (16)
Severity on admission, n. (%)
Mental status change 4 (5)
PSI Risk Class IV and V 54 (72)
PSI Risk Class V 21 (28)
Acute respiratory failure 39 (52)
Severe sepsis 14 (19)
Clinical and laboratory data on admission, median (IQR)
Heart rate, bpm 80 (71–92)
Respiratory rate, bpm 20 (18–25)
Systolic blood pressure, mmHg 128 (115–146)
Diastolic blood pressure, mmHg 70 (60–80)
White blood cells, cell/L−1 11,840 (9180–15,900)
Hemoglobin, g/dL 12.6 (11–14.2)
Hematocrit, % 37 (33–41)
Albumin, g/dL 3.3 (3.1–3.8)
Table 1 Baseline demographics, comorbidities, disease severity,
clinical and laboratory findings on admission, microbiology, and
antibiotic therapy of the study population (Continued)
Platelets, cell/L−1 196,000 (161,000–289,000)
Lactate dehydrogenase, mg/dL 378 (318–444)
Blood urea nitrogen, mg/dL 40 (27–49)
Creatinine, mg/dL 1 (0.8–1.3)
Sodium, mEq/L 136 (133–139)
Potassium, mEq/L 4 (3.7–4.4)
Glucose, mg/dL 119 (106–146)
C-reactive protein, mg/L 12.9 (6.25–28.8)
pH 7.46 (7.44–7.48)
Microbiology, n. (%)
Isolated pathogen 13 (17)
S. pneumoniae 8 (11)
S. aureus 2 (3)
Legionella pneumophila 2 (3)
P. aeruginosa 1 (1)
Empiric antibiotic treatment, n. (%)
Ceftriaxone 36 (48)
Azithromycin 38 (51)
Levofloxacin 32 (43)
Ceftazidime 8 (11)
Piperacillin/tazobactam 9 (12)
Others 23 (30)
n. number, IQR 25–75 interquartile range, PSI pneumonia severity index
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after adjustment for the severity of the disease on admis-
sion, CAP patients showing a delay in reaching clinical
stability, had lower total power and lower sympathetic
modulation on hospital admission.
Our data seem to be in line with previous experiences
performed in septic patients. During sepsis, a lower total
variability, which represents the capability of the cardio-
vascular system of responding to external perturbations
and impaired sympathetic modulation characterizes
CAC and the lower the total variability, the more severe
is sepsis [12, 24]. So far, no data have been reported on
the evaluation of the cardiac autonomic control in a
homogenous population of hospitalized patients with pneu-
monia. A common expectation would be an increase of
sympathetic activity, as previously hypothesized [8]. How-
ever, we found a loss of rhythmical properties of sympa-
thetic discharge and a predominant respiratory modulation
in CAP patients. These finding suggest that the events that
occur during pneumonia, including a systemic inflamma-
tory response and impairment in gas exchange, could affect
the central rhythmic organization of autonomic control.
This is similar to what occurs in patients with congestive
heart failure (CHF). Studies in patients with CHF evaluating
muscle sympathetic nerve activity (MSNA) showed a high
sympathetic activity, positively correlated with the severity
of the disease, but a lower total variability and sympathetic
oscillation, with a relative predominance of the parasympa-
thetic oscillation [25]. In CHF patients, this occurs when
central and peripheral reflexes, mediated by respiration,
baroreceptors and chemoreceptors, loose their ability
to rhythmically inhibits central sympathetic activity.
Therefore, a parallel decrease in LFnu modulation and
total variability is a marker of an increased sympathetic
activity associated with the loss of its physiological
rhythmical properties, and this is associated with a poorer
prognosis [11, 19, 25].
Inflammatory reflex, through the activation of vagus
nerve, controls the immune response to injury [26].
Alterations of CAC we found in CAP patients could be
seen as the final consequence of a complex interaction
between systemic inflammation, that could trigger the
inflammatory reflex, and hypoxia, that could trigger cen-
tral and peripheral autonomic reflexes. Autonomic alter-
ations in this population, characterized by a lower level of
total variability and a reduction of LF components, could
be partially related to the activation of the above men-
tioned excitatory different reflexes and these results were
more evident in patients with severe CAP, compared to
those without severe CAP on admission. In summary,
CAP patients with a more severe disease on admission
seem to show a loss of rhythmic sympathetic oscillation,
with a predominant respiratory oscillation characterizing
HRV. These findings were consistent across different eval-
uations of the severity of the disease on admission.
Finally, when we evaluated an early clinical outcome in
our population, we found that total power and 0V% were
significantly lower among those with a delay in reaching
clinical stability, as confirmed in the multivariable ap-
proach. We already know from previous literature that
a reduction of total power is strongly associated with
poor outcomes in several cardiovascular diseases, in-
cluding myocardial infarction, CHF, and major arrh-
ythmias [10, 11]. Few other studies identified HRV as
prognostic factor in patients with sepsis. A reduction of
Table 2 Autonomic parameters evaluated by both spectral and symbolic analysis in patients with community-acquired pneumonia
(CAP) and controls
CAP patients n = 75 Controls n = 26 p
Parameter
Heart rate, median (IQR) bpm 80 (71–92) 68 (60–73) 0.006
Spectral analysis
Total power, median (IQR) ms2 159 (79–368) 522 (335–1760) <0.001
VLF, median (IQR) ms2 49 (0–121) 262 (99–983) <0.001
LFnu, median (IQR) 32 (11–63) 56 (37–75) 0.008
HFnu, median (IQR) 42 (13–59) 41 (22–55) 0.935
LF/HF, median (IQR) 0.92 (0.23–2.6) 1.3 (0.73–3.1) 0.120
HF Hz, median (IQR) 0.31 (0.27–0.37) 0.29 (0.26–0.33) 0.096
Symbolic analysis
0V, median (IQR) % 26 (13–38) 30 (12–46) 0.451
1V, median (IQR) % 39 (33–47) 44 (38–49) 0.077
2LV, median (IQR) % 4.4 (2.2–8.5) 6.0 (3.5–12) 0.164
2UV, median (IQR) % 24 (12–41) 17 (12–24) 0.020
n. number, IQR 25–75 interquartile range, bpm beats per minute, ms2 milliseconds2, VLF very low frequency, LF low frequency, HF high frequency, nu normalized
units, Hz Hertz
Aliberti et al. Respiratory Research  (2016) 17:98 Page 5 of 8
total variability and LF and higher HF are associated
with poor in-hospital outcome and poor short-term
prognosis in septic patients [12, 24, 27, 28].
Our results might have important clinical implications
in light of the occurrence of cardiovascular events in up to
30 % of hospitalized patients with CAP with an increase
in both short and long-term mortality [2]. Previous litera-
ture has showed that a deregulation of the sympatho-vagal
balance increases cardiovascular risk in cardiac patients
[9–11]. Our results provide important physiopathological
elements, which can be used for the risk stratification of
CAP patients. We could speculate that a deregulation of
CAC characterized by a reduction of total variability and
loss of sympathetic rhythmical property could be related
and/or predict the onset of cardiovascular events and
mortality in CAP patients. Now, we cannot speculate that
a specific treatment directed towards alteration of CAC
might help in reducing cardiovascular complications in
CAP patients. We suggest future ad hoc clinical studies
to correlate the autonomic dysfunction to cardiovascu-
lar morbidity and mortality in CAP patients as well as
interventional studies to restore sympathetic rhythmical
discharge are required.
One of the major limitations of our study was the
absence of a direct evaluation of the sympathetic activity
using MSNA. However, MSNA is an invasive technique
that is difficult to apply in acute patients. We decided to
evaluate CAC only on admission, while other evaluations
during hospitalization or even after hospital discharge
could provide information during both treatment and
recovery from pneumonia. Biochemical assessments of
serum cytokines levels or other markers of systemic in-
flammation have not been performed. The analysis and
interpretation of HRV in CAP patients may be challenging
because when breathing is more vigorous, respiratory
fluctuations may dominate HRV. Paced breathing could
have added additional information in our study. We in-
cluded CAP patients independently from the presence of
cardiovascular comorbidity in order to evaluate a popula-
tion close to real life. Among them, some were on beta-
blockers that might affect CAC. Due to small sample size,
we were not able to correct for this important confounder,
Fig. 1 Evaluation of cardiac autonomic control in the study population, according to presence of severe community-acquired pneumonia (CAP)
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while we suggest future studies including a larger sample of
CAP patients to take into account not only beta-blockers
but also other drugs, which could possibly affect CAC. In
addition, a sub-group analysis on patients with bacteremia
would have been very important, but unfortunately, we had
only 3 patients with bacteremia, and we were not able to
perform any specific analysis on them. Finally, the small
sample size allowed us to investigate neither a specific
population of bacteraemic patients nor a possible relation-
ship between CAC and pathogens causing pneumonia.
On the other hand, this was the first pilot experience
evaluating the cardiovascular autonomic modulation in
hospitalized patients with CAP according to both different
markers of the severity of the diseases and early clinical out-
come. All the findings were consistent through the evalu-
ation of the severity of the disease on admission and
clinical outcomes and our results were strengthened by the
use of two different tools, spectral and symbolic analysis,
able to provide complementary information on CAC.
Conclusions
CAC is altered in CAP patients, with a lower sympathetic
modulation and a predominant parasympathetic oscillatory
rhythm, especially among those with severe CAP. CAP
patients showing a delay in reaching clinical stability during
hospitalization show a significant lower total variability
on hospital admission. Our results may provide important
physiopathological elements to stratify CAP patients in
terms of disease severity and cardiovascular morbidity
and mortality. Further studies should be focused on the
evaluation of the impact of CAC on the occurrence of
cardiovascular events both during hospitalization and after
discharge and on late clinical outcomes in larger cohorts
of CAP patients.
Additional file
Additional file 1: Autonomic cardiac parameters in patients with and
without severe community-acquired pneumonia (CAP) on hospital admis-
sion. (DOC 84 kb)
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